Jefferies Financial Group Inc. Has $1.24 Million Stake in Henry Schein, Inc. $HSIC

Jefferies Financial Group Inc. cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 46.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,977 shares of the company’s stock after selling 14,733 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Henry Schein were worth $1,240,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in HSIC. Choreo LLC acquired a new stake in Henry Schein during the 1st quarter valued at $224,000. Cetera Investment Advisers raised its position in shares of Henry Schein by 14.7% in the first quarter. Cetera Investment Advisers now owns 4,924 shares of the company’s stock valued at $337,000 after purchasing an additional 630 shares during the period. Assetmark Inc. lifted its stake in shares of Henry Schein by 24,700.0% during the 1st quarter. Assetmark Inc. now owns 6,200 shares of the company’s stock worth $425,000 after buying an additional 6,175 shares during the last quarter. HB Wealth Management LLC boosted its holdings in shares of Henry Schein by 1.5% during the 1st quarter. HB Wealth Management LLC now owns 15,419 shares of the company’s stock worth $1,056,000 after buying an additional 226 shares during the period. Finally, Federated Hermes Inc. grew its stake in Henry Schein by 766.5% in the 1st quarter. Federated Hermes Inc. now owns 2,045 shares of the company’s stock valued at $140,000 after buying an additional 1,809 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 0.3%

HSIC opened at $75.25 on Thursday. The stock has a market capitalization of $8.86 billion, a price-to-earnings ratio of 24.27, a P/E/G ratio of 2.06 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a 50-day simple moving average of $67.47 and a 200 day simple moving average of $69.34.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Evercore ISI raised their price objective on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. Wells Fargo & Company increased their target price on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 5th. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Barrington Research set a $79.00 price objective on Henry Schein and gave the company an “outperform” rating in a report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. lifted their target price on Henry Schein from $76.00 to $78.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Henry Schein currently has an average rating of “Hold” and a consensus price target of $76.08.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.